|
Diabetes Care, Vol 16, Issue 8 1131-1136, Copyright © 1993 by American Diabetes Association
Alanine and terbutaline in treatment of hypoglycemia in IDDM
BV Wiethop and PE Cryer
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
OBJECTIVE--To test the hypothesis that, in contrast to administration of
glucose or glucagon, administration of the amino acid Ala or of the beta
2-adrenergic agonist terbutaline produces sustained glucose recovery from
hypoglycemia. RESEARCH DESIGN AND METHODS--We developed a model of clinical
hypoglycemia using subcutaneous injection of insulin (0.15 U/kg) in
patients with IDDM. In comparison with nondiabetic subjects, patients with
IDDM exhibited reduced glucagon (P = 0.0001), epinephrine (P = 0.0060), and
pancreatic polypeptide (P = 0.0001) responses to hypoglycemia. In addition
to placebos, the following were administered during hypoglycemia (2 h after
insulin injection) in IDDM patients: oral glucose, 10 and 20 g;
subcutaneous glucagon, 1.0 mg; oral Ala, 40 g; oral terbutaline, 5.0 mg;
and subcutaneous terbutaline, 0.25 mg. RESULTS--Glucose (10 and 20 g) and
glucagon raised plasma glucose (P = 0.0163, 0.0060, and 0.0001,
respectively) from 3.0-3.3 mM to peaks of 5.4 +/- 0.4, 6.8 +/- 0.7, and
11.8 +/- 0.8 mM within 30, 45, and 60 min, respectively, but the responses
were transient. Oral Ala raised glucose levels (P = 0.0401) to 4.0 +/- 0.4
mM within 30 min; glucose levels then rose gradually to a 6-h value of only
7.1 +/- 0.9 mM. Oral terbutaline raised glucose levels (P = 0.0294) to 4.3
+/- 0.3 mM within 30 min; glucose levels then rose substantially. In
contrast, subcutaneous terbutaline raised glucose levels (P = 0.0249) to
3.7 +/- 0.1 mM within 15 min; the levels plateaued at 5.0 mM from
approximately 60-150 min and then paralleled the placebo curve.
CONCLUSIONS--Ala and terbutaline produce sustained glucose recovery from
hypoglycemia in IDDM and are therefore potentially useful agents for the
treatment of mild or moderate iatrogenic hypoglycemia, or the prevention of
iatrogenic hypoglycemia, when food intake is not anticipated over the
following several hours.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Rossetti, F. Porcellati, N. Busciantella Ricci, P. Candeloro, P. Cioli, K. S. Nair, F. Santeusanio, G. B. Bolli, and C. G. Fanelli
Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People
Diabetes,
July 1, 2008;
57(7):
1905 - 1917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. De Galan, P. De Mol, L. Wennekes, B. J. J. Schouwenberg, and P. Smits
Preserved Sensitivity to {beta}2-Adrenergic Receptor Agonists in Patients with Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
J. Clin. Endocrinol. Metab.,
August 1, 2006;
91(8):
2878 - 2881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Raju, A. M. Arbelaez, S. M. Breckenridge, and P. E. Cryer
Nocturnal Hypoglycemia in Type 1 Diabetes: An Assessment of Preventive Bedtime Treatments
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2087 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Venters, A. E. Hunt, J. F. Pope, and E. F. Molaison
Are Patients With Diabetes Receiving the Same Message From Dietitians and Nurses?
The Diabetes Educator,
March 1, 2004;
30(2):
293 - 300.
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer, S. N. Davis, and H. Shamoon
Hypoglycemia in Diabetes
Diabetes Care,
June 1, 2003;
26(6):
1902 - 1912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N P Wright and J K H Wales
The incidence of hypoglycaemia in children with type 1 diabetes and treated asthma
Arch. Dis. Child.,
February 1, 2003;
88(2):
155 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Chan, S. Chan, K. Inouye, K. Shum, S. G. Matthews, and M. Vranic
Diabetes Impairs Hypothalamo-Pituitary-Adrenal (HPA) Responses to Hypoglycemia, and Insulin Treatment Normalizes HPA but not Epinephrine Responses
Diabetes,
June 1, 2002;
51(6):
1681 - 1689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al.
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
Diabetes Care,
January 1, 2002;
25(1):
148 - 198.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer and B. P. Childs
Negotiating the Barrier of Hypoglycemia in Diabetes
Diabetes Spectr,
January 1, 2002;
15(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cersosimo, P. Garlick, and J. Ferretti
Abnormal Glucose Handling by the Kidney in Response to Hypoglycemia in Type 1 Diabetes
Diabetes,
September 1, 2001;
50(9):
2087 - 2093.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1993 by the American Diabetes Association.
|
|
| |
|